mutual funds edelweiss msci india domestic world healthcare 45 index fund directgrowth

holdings

ℹ️ Lumpsum Investments have been temporarily suspended

Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct-Growth

Equity: Sectoral-Pharma - Growth (Open ended)

Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct-GrowthNAV: 23.91 as on 07 Jul, 2026

Risk levelCategoryBenchmark

Factsheet

SEBI Riskometer: Very HighCategory: Equity: Sectoral-PharmaBenchmark: MSCI India Domestic & World Healthcare 45 Index

NAV: ₹23.91-0.03%

08 Jul 2026

Holdings Analysis

Equity, debt and cash allocation snapshot with market cap distribution for Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct-Growth.

Asset Allocation

As on 31 May 2026

Equity

99.67%

Debt

0.30%

Others

0.03%

Market Cap Distribution

Large Cap (41.0%)

Mid Cap (38.5%)

Small Cap (20.5%)

Historical Asset Allocation

Asset	31 May 2026	30 Apr 2026	31 Mar 2026	28 Feb 2026	31 Jan 2026	31 Dec 2025
Equity	99.67%	99.70%	99.50%	99.68%	99.82%	99.94%
Debt	0.30%	0.27%	0.26%	0.15%	0.27%	0.16%
Others (incl. cash)	0.03%	0.02%	0.24%	0.17%	-0.09%	-0.10%
Commodities	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Real Estate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Portfolio Snapshot

No. of Securities

P/E Ratio

44.15

P/B Ratio

5.92

Top Holding %

11.42%

Top 5 Holdings %

34.26%

Top 10 Holdings %

55.08%

AUM

₹178 Cr

Expense Ratio

0.54%

Since Inception

16.79%

Max Drawdown

-0.16%

Alpha

1.91%

Sharpe Ratio

1.12

Top Portfolio Holdings by Weight

Latest portfolio holdings sorted by allocation weight. Includes instrument name, sector, number of shares, market value (₹ Cr) and percentage of net assets. Switch dates or categories using the controls below.

Instrument	Sector	No. of Shares	Value (Rs. Cr)	Weight	Change
Sun Pharmaceutical Industries Ltd.	Healthcare	1,13,068	20.34	11.42%	-0.48%↓
Apollo Hospitals Enterprise Ltd.	Healthcare	12,705	10.39	5.83%	0.18%↑
Divis Laboratories Ltd.	Healthcare	14,074	9.38	5.27%	-0.06%↓
Cipla Ltd.	Healthcare	66,617	9.33	5.24%	0.16%↑
Max Healthcare Institute Ltd.	Healthcare	91,707	8.85	4.97%	-0.33%↓
Dr. Reddys Laboratories Ltd.	Healthcare	63,913	8.33	4.68%	-0.24%↓
Lupin Ltd.	Healthcare	29,600	6.71	3.77%	-0.20%↓
Torrent Pharmaceuticals Ltd.	Healthcare	13,955	6.16	3.46%	0.06%↑
Laurus Labs Ltd.	Healthcare	41,342	5.63	3.16%	0.51%↑
Fortis Healthcare Ltd.	Healthcare	57,814	5.37	3.01%	-0.10%↓
Aurobindo Pharma Ltd.	Healthcare	30,792	4.39	2.47%	-0.02%↓
Glenmark Pharmaceuticals Ltd.	Healthcare	18,286	4.16	2.34%	-0.22%↓
Mankind Pharma Ltd.	Healthcare	14,590	3.47	1.95%	0.04%↑
Alkem Laboratories Ltd.	Healthcare	5,635	3.1	1.74%	-0.03%↓
Biocon Ltd.	Healthcare	71,077	3.05	1.71%	0.22%↑
Zydus Lifesciences Ltd.	Healthcare	23,710	2.56	1.43%	0.20%↑
Ipca Laboratories Ltd.	Healthcare	16,437	2.51	1.41%	-0.05%↓
JB Chemicals & Pharmaceuticals Ltd.	Healthcare	10,151	2.2	1.24%	0.03%↑
Aster DM Healthcare Ltd.	Healthcare	27,469	2	1.12%	-0.00%↓
Gland Pharma Ltd.	Healthcare	8,735	1.97	1.10%	0.21%↑

1 / 2

Sector-wise Portfolio Allocation

Equity exposure by sector as a percentage of total net assets, tracked across recent portfolio dates. Identifies concentration risk and sector rotation trends in the fund's holdings.

Sector	31 May 2026	30 Apr 2026	31 Mar 2026	28 Feb 2026	31 Jan 2026	31 Dec 2025
Healthcare	99.67%	99.70%	99.50%	99.68%	99.82%	99.94%

Equity Insights

A detailed look at the equity holdings of this scheme — aggregated scores on value, momentum, quality parameters along with diversification and performance analysis.

Style Analysis

Value score

29.5 / 100

Weighted average Value score is 29.5. This indicates that portfolio is relatively reasonably valued using composite of value measures.

Price Momentum score

80.8 / 100

Weighted average Price Momentum score is 80.8. This indicates that portfolio has high momentum using composite of momentum measures.

Quality score

87.5 / 100

Weighted average Quality score is 87.5. This indicates that portfolio has high quality using composite of quality measures.

QVM score

78.9 / 100

Weighted average QVM score is 78.9. This indicates that portfolio has high QVM score and hence could be considered for investment.

Red Flags

No red flags found!

None of the stocks in the portfolio show significant red flags.

Frequently Asked Questions

What are the top holdings of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct-Growth?

The top holdings of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct-Growth sorted by portfolio weight are listed in the Top Portfolio Holdings section of the Holdings tab.

How many stocks does Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct-Growth hold in its portfolio?

Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct-Growth holds 46 securities in its portfolio. The top 5 holdings account for 34.26% of the portfolio and the top 10 for 55.08%.

What is the sector allocation of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct-Growth?

The sector allocation of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct-Growth is in the Sector Allocation section, showing each industry's weight in the portfolio.

What is the equity and debt allocation of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct-Growth?

As of 31 May 2026, Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct-Growth has 99.67% in equity, 0.30% in debt and 0.03% in cash/others. This asset mix determines the fund's overall risk-return profile.

What is the market cap allocation of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct-Growth?

Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct-Growth's equity portfolio — Large Cap: 41.01%, Mid Cap: 38.49%, Small Cap: 20.51%. Market cap allocation determines the fund's risk profile — large cap offers stability while mid and small cap offer higher growth potential with higher volatility.

Is Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct-Growth a concentrated or diversified fund?

Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct-Growth holds 46 securities, with the top 10 accounting for 55.08% of the portfolio and the top 5 for 34.26%. This is a moderately diversified fund balancing conviction positions with risk spread.

What is the credit quality of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct-Growth?

The credit quality breakdown of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct-Growth's debt portfolio is in the Credit Rating section. For equity-oriented funds, this section may not be applicable.

How often does Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct-Growth change its portfolio?

The portfolio currently holds 46 securities with the top 10 accounting for 55.08% as of 31 May 2026. Portfolio turnover reflects how actively the fund manager trades. A high turnover increases transaction costs while a low turnover reflects a buy-and-hold approach. Historical asset allocation snapshots across multiple dates are in the Holdings Analysis section.

What is the PE ratio of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct-Growth's portfolio?

The weighted average PE ratio of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct-Growth's portfolio is 44.15 and the PB ratio is 5.92. These metrics reflect the overall valuation and interest rate sensitivity of the portfolio.

When is the latest portfolio disclosure for Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct-Growth?

The latest portfolio disclosure for Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct-Growth is as of 31 May 2026. Mutual funds and ETFs in India are required to disclose their full portfolio monthly, within 10 business days of month-end. You can switch between historical disclosure dates using the date selector in the Top Portfolio Holdings section.

Loading…

Asset

31 May 2026

30 Apr 2026

31 Mar 2026

28 Feb 2026

31 Jan 2026

31 Dec 2025

Equity

99.67%

99.70%

99.50%

99.68%

99.82%

99.94%

Debt

0.30%

0.27%

0.26%

0.15%

0.27%

0.16%

Others (incl. cash)

0.03%

0.02%

0.24%

0.17%

-0.09%

-0.10%

Commodities

0.00%

Real Estate

0.00%

Instrument

Sector

No. of Shares

Value (Rs. Cr)

Weight

Change

Sun Pharmaceutical Industries Ltd.

Healthcare

1,13,068

20.34

11.42%

-0.48%↓

Apollo Hospitals Enterprise Ltd.

Healthcare

12,705

10.39

5.83%

0.18%↑

Divis Laboratories Ltd.

Healthcare

14,074

9.38

5.27%

-0.06%↓

Cipla Ltd.

Healthcare

66,617

9.33

5.24%

0.16%↑

Max Healthcare Institute Ltd.

Healthcare

91,707

8.85

4.97%

-0.33%↓

Dr. Reddys Laboratories Ltd.

Healthcare

63,913

8.33

4.68%

-0.24%↓

Lupin Ltd.

Healthcare

29,600

6.71

3.77%

-0.20%↓

Torrent Pharmaceuticals Ltd.

Healthcare

13,955

6.16

3.46%

0.06%↑

Laurus Labs Ltd.

Healthcare

41,342

5.63

3.16%

0.51%↑

Fortis Healthcare Ltd.

Healthcare

57,814

5.37

3.01%

-0.10%↓

Aurobindo Pharma Ltd.

Healthcare

30,792

4.39

2.47%

-0.02%↓

Glenmark Pharmaceuticals Ltd.

Healthcare

18,286

4.16

2.34%

-0.22%↓

Mankind Pharma Ltd.

Healthcare

14,590

3.47

1.95%

0.04%↑

Alkem Laboratories Ltd.

Healthcare

5,635

3.1

1.74%

-0.03%↓

Biocon Ltd.

Healthcare

71,077

3.05

1.71%

0.22%↑

Zydus Lifesciences Ltd.

Healthcare

23,710

2.56

1.43%

0.20%↑

Ipca Laboratories Ltd.

Healthcare

16,437

2.51

1.41%

-0.05%↓

JB Chemicals & Pharmaceuticals Ltd.

Healthcare

10,151

2.2

1.24%

0.03%↑

Aster DM Healthcare Ltd.

Healthcare

27,469

1.12%

-0.00%↓

Gland Pharma Ltd.

Healthcare

8,735

1.97

1.10%

0.21%↑